Home
About
FAQ
History (10)
Comparison of plasma biomarkers and amyloid PET for predicting memory decline in cognitively unimpaired individuals.
Liver integrity and the risk of Alzheimer's disease and related dementias.
Restrictions on blood donations relevant to dermatology.
Acceptable performance of blood biomarker tests of amyloid pathology - recommendations from the Global CEO Initiative on Alzheimer's Disease.
Alzheimer disease blood biomarkers: considerations for population-level use.
See All 10 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Alzheimer disease blood biomarkers: considerations for population-level use.
Mielke MM, Fowler NR. Alzheimer disease blood biomarkers: considerations for population-level use. Nat Rev Neurol. 2024 Aug; 20(8):495-504.
View in:
PubMed
subject areas
Alzheimer Disease
Humans
authors with profiles
Michelle M. Mielke PhD